{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T17:04:43Z","timestamp":1790960683704,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100018731","name":"Jiangsu Hengrui Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018731","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.jad.2025.120842","type":"journal-article","created":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T07:38:23Z","timestamp":1765006703000},"page":"120842","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Dexmedetomidine nasal spray for acute agitation in adults with bipolar disorder: a single-arm open-label trial"],"prefix":"10.1016","volume":"396","author":[{"given":"Gui","family":"Gui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaohua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2025.120842_bb0005","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.genhosppsych.2003.08.002","article-title":"Use of restraints and pharmacotherapy in academic psychiatric emergency services","volume":"26","author":"Allen","year":"2004","journal-title":"Gen. Hosp. Psychiatry"},{"key":"10.1016\/j.jad.2025.120842_bb0010","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.genhosppsych.2003.08.002","article-title":"Use of restraints and pharmacotherapy in academic psychiatric emergency services","volume":"26","author":"Allen","year":"2004","journal-title":"Gen. Hosp. Psychiatry"},{"key":"10.1016\/j.jad.2025.120842_bb0015","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1590\/1516-4446-2018-0177","article-title":"Brazilian guidelines for the management of psychomotor agitation. Part 2. Pharmacological approach","volume":"41","author":"Balda\u00e7ara","year":"2019","journal-title":"Braz. J. Psychiatry"},{"key":"10.1016\/j.jad.2025.120842_bb0020","first-page":"28","article-title":"The clinical global impressions scale","volume":"4","author":"Busner","year":"2007","journal-title":"Psychiatry (Edgmont)"},{"key":"10.1016\/j.jad.2025.120842_bb0025","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.aan.2022.06.003","article-title":"What is the role of dexmedetomidine in modern anesthesia and critical care?","volume":"40","author":"Chima","year":"2022","journal-title":"Adv. Anesth."},{"key":"10.1016\/j.jad.2025.120842_bb0030","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/j.1742-1241.2010.02615.x","article-title":"Aerosolised antipsychotic assuages agitation: inhaled loxapine for agitation associated with schizophrenia or bipolar disorder: inhaled loxapine for agitation","volume":"65","author":"Citrome","year":"2011","journal-title":"Int. J. Clin. Pract."},{"key":"10.1016\/j.jad.2025.120842_bb0035","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.22m14447","article-title":"Sublingual dexmedetomidine for the treatment of acute agitation in adults with schizophrenia or schizoaffective disorder: a randomized placebo-controlled trial","volume":"83","author":"Citrome","year":"2022","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2025.120842_bb0040","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.2147\/NDT.S173567","article-title":"Examining the safety, efficacy, and patient acceptability of inhaled loxapine for the acute treatment of agitation associated with schizophrenia or bipolar I disorder in adults","volume":"15","author":"Faden","year":"2019","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.jad.2025.120842_bb0045","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1186\/s12871-024-02708-1","article-title":"Safety and efficacy of a novel dexmedetomidine nasal spray for pre-anesthetic sedation in children: a randomized, double-blind, placebo-controlled trial","volume":"24","author":"Gao","year":"2024","journal-title":"BMC Anesthesiol."},{"key":"10.1016\/j.jad.2025.120842_bb0050","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3109\/15622975.2015.1132007","article-title":"Assessment and management of agitation in psychiatry: expert consensus","volume":"17","author":"Garriga","year":"2016","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2025.120842_bb0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5811\/westjem.2011.9.6865","article-title":"Overview of project BETA: best practices in evaluation and treatment of agitation","volume":"13","author":"Holloman","year":"2012","journal-title":"West. J. Emerg. Med."},{"key":"10.1016\/j.jad.2025.120842_bb0060","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1176\/ajp.154.11.1525","article-title":"PET evidence that loxapine is an equipotent blocker of 5-HT2 and D2 receptors: implications for the therapeutics of schizophrenia","volume":"154","author":"Kapur","year":"1997","journal-title":"Am. J. Psychiatry"},{"issue":"2","key":"10.1016\/j.jad.2025.120842_bb0065","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1080\/14740338.2021.1865911","article-title":"Safety and efficacy of pharmacologic agents used for rapid tranquilization of emergency department patients with acute agitation or excited delirium","volume":"20","author":"Kim","year":"2021","journal-title":"Expert Opin Drug Saf."},{"key":"10.1016\/j.jad.2025.120842_bb0075","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1399-5618.2011.00975.x","article-title":"Rapid acute treatment of agitation in patients with bipolar I disorder: a multicenter, randomized, placebo-controlled clinical trial with inhaled loxapine","volume":"14","author":"Kwentus","year":"2012","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2025.120842_bb0080","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.bja.2017.11.100","article-title":"Pharmacokinetic and pharmacodynamic study of intranasal and intravenous dexmedetomidine","volume":"120","author":"Li","year":"2018","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.jad.2025.120842_bb0085","series-title":"A Review of Agitation in Mental Illness: Treatment Guidelines and Current Therapies","author":"Marder","year":"2006"},{"key":"10.1016\/j.jad.2025.120842_bb0090","first-page":"54","article-title":"1st international experts\u2019 meeting on agitation: conclusions regarding the current and ideal management paradigm of agitation","volume":"9","author":"Mart\u00ednez-Raga","year":"2018","journal-title":"Front. Psychol."},{"key":"10.1016\/j.jad.2025.120842_bb0095","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.annemergmed.2018.06.001","article-title":"The characteristics and prevalence of agitation in an urban county emergency department","volume":"72","author":"Miner","year":"2018","journal-title":"Ann. Emerg. Med."},{"key":"10.1016\/j.jad.2025.120842_bb0100","series-title":"Treatment of Acute Agitation in Psychotic Disorders","author":"Mohr","year":"2005"},{"key":"10.1016\/j.jad.2025.120842_bb0105","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1477-7525-9-18","article-title":"Validation of the excited component of the Positive and Negative Syndrome Scale (PANSS-EC) in a naturalistic sample of 278 patients with acute psychosis and agitation in a psychiatric emergency room","volume":"9","author":"Montoya","year":"2011","journal-title":"Health Qual. Life Outcomes"},{"key":"10.1016\/j.jad.2025.120842_bb0110","first-page":"26","article-title":"Issues in the management of acute agitation: how much current guidelines consider safety?","volume":"4","author":"Pacciardi","year":"2013","journal-title":"Front. Psychol."},{"key":"10.1016\/j.jad.2025.120842_bb0115","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2165\/00148581-200810010-00006","article-title":"Clinical uses of dexmedetomidine in pediatric patients","volume":"10","author":"Phan","year":"2008","journal-title":"Pediatr. Drugs"},{"key":"10.1016\/j.jad.2025.120842_bb0120","doi-asserted-by":"crossref","first-page":"4368","DOI":"10.3390\/ijerph18084368","article-title":"The management of psychomotor agitation associated with schizophrenia or bipolar disorder: a brief review","volume":"18","author":"Pompili","year":"2021","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.jad.2025.120842_bb0125","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.2165\/00003088-200544110-00002","article-title":"Pharmacokinetics and therapeutics of acute intramuscular ziprasidone","volume":"44","author":"Preskorn","year":"2005","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.jad.2025.120842_bb0130","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1001\/jama.2022.0799","article-title":"Effect of sublingual dexmedetomidine vs placebo on acute agitation associated with bipolar disorder","volume":"327","author":"Preskorn","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.jad.2025.120842_bb0135","doi-asserted-by":"crossref","first-page":"17","DOI":"10.5811\/westjem.2011.9.6864","article-title":"Verbal de-escalation of the agitated patient: consensus statement of the American Association for Emergency Psychiatry Project BETA De-escalation workgroup","volume":"13","author":"Richmond","year":"2012","journal-title":"West. J. Emerg. Med."},{"key":"10.1016\/j.jad.2025.120842_bb0140","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s12888-018-1673-3","article-title":"Characterizing the experience of agitation in patients with bipolar disorder and schizophrenia","volume":"18","author":"Roberts","year":"2018","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.jad.2025.120842_bb0145","series-title":"A Review of Agitation in Mental Illness: Burden of Illness and Underlying Pathology","author":"Sachs","year":"2006"},{"key":"10.1016\/j.jad.2025.120842_bb0150","article-title":"The mini-international neuropsychiatric interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10","volume":"59","author":"Sheehan","year":"1998","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2025.120842_bb0155","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/bdi.12062","article-title":"A double-blind, placebo-controlled study of adjunctive calcitonin nasal spray in acute refractory mania","volume":"15","author":"Vik","year":"2013","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2025.120842_bb0160","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.jemermed.2019.07.019","article-title":"Characteristics and severity of agitation associated with use of sedatives and restraints in the emergency department","volume":"57","author":"Wong","year":"2019","journal-title":"J. Emerg. Med."},{"key":"10.1016\/j.jad.2025.120842_bb0165","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1176\/appi.ajp.158.7.1149","article-title":"Double-blind, placebo-controlled comparison of intramuscular olanzapine and intramuscular haloperidol in the treatment of acute agitation in schizophrenia","volume":"158","author":"Wright","year":"2001","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2025.120842_bb0170","doi-asserted-by":"crossref","first-page":"e1788","DOI":"10.1097\/MJT.0000000000000319","article-title":"Safety and efficacy of dexmedetomidine as a sedative agent for performing awake intubation: a meta-analysis","volume":"23","author":"Zhou","year":"2016","journal-title":"Am. J. Ther."}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032725022840?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032725022840?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T18:30:38Z","timestamp":1768415438000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032725022840"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":33,"alternative-id":["S0165032725022840"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2025.120842","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dexmedetomidine nasal spray for acute agitation in adults with bipolar disorder: a single-arm open-label trial","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2025.120842","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"120842"}}